BlackRock Fund Advisors’s Immune Design Corp. IMDZ Stock Holding History

BlackRock Fund Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.44M	Sell	443,790 -207,936	-32%	-$1.47M	﹤0.01%	3125
2016 Q3	$4.94M	Buy	651,726 +101,990	+19%	+$746K	﹤0.01%	2850
2016 Q2	$4.49M	Sell	549,736 -7,691	-1%	-$95.9K	﹤0.01%	2858
2016 Q1	$7.25M	Buy	557,427 +17,741	+3%	+$205K	﹤0.01%	2537
2015 Q4	$10.8M	Buy	539,686 +243,217	+82%	+$4.19M	﹤0.01%	2402
2015 Q3	$3.62M	Sell	296,469 -382	-0.1%	-$7.16K	﹤0.01%	2955
2015 Q2	$6.13M	Buy	296,851 +124,699	+72%	+$2.95M	﹤0.01%	2803
2015 Q1	$3.63M	Buy	172,152 +4,283	+3%	+$112K	﹤0.01%	2985
2014 Q4	$5.17M	Buy	167,869 +17,931	+12%	+$498K	﹤0.01%	2857
2014 Q3	$2.65M	Buy	+149,938	New	+$1.9M	﹤0.01%	3069

Other funds holding IMDZ

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's IMDZ Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Immune Design Corp. (IMDZ) stake by 32% in Q4 2016, selling an estimated $1.47M and leaving 443,790 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3125.

BlackRock Fund Advisors first reported a position in IMDZ in Q3 2014 and has held it in 10 quarters since. The position peaked at $10.8M in Q4 2015. 65 funds tracked by Wall St. Rank hold IMDZ as of Q4 2016.

BlackRock Fund Advisors held 443,790 shares of Immune Design Corp. worth $2.44M as of Q4 2016.
BlackRock Fund Advisors sold 207,936 Immune Design Corp. shares in Q4 2016, an estimated $1.47M.
Immune Design Corp. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3125 holding.
BlackRock Fund Advisors first reported a position in Immune Design Corp. in Q3 2014 and has held it in 10 quarters since.
BlackRock Fund Advisors's Immune Design Corp. position peaked at $10.8M in Q4 2015.
65 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.